Nebulizers Market is expected to reach USD 1,629.7 Million at a CAGR 7.32% from 2020 to 2027.
Nebulizers Market is expected to hold a value of USD 1,629.7 Million by 2027 and is expected to register a growth of 7.32% from 2020 to 2027. Nebulizers are a device that has the capability of changing a medication from a liquid to a mist so that it can be inhaled into the lungs. High demand for respiratory devices, including nebulizers, due to the outbreak of COVID-19 globally, growing need for rescue medication, increasing prevalence of respiratory diseases, and rising demand for home healthcare devices are the key factors that are expected to drive the market growth. Moreover, the growing geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products may lead to respiratory diseases, and the rising number of initiatives taken by the government as well as the private organizations are also expected to boost the nebulizers market growth. The outbreak of COVID-19, leading to increased demand for respiratory devices, including nebulizers.
Nebulizers Market Drivers
Nebulizers Market Segmentation
Nebulizers Market Key Players
|Market Size||2027: USD 1,629.7 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Usage, Portability and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||OMRON Healthcare (Japan), Koninklijke Philips N.V. (Netherlands), PARI (US), Vectura Group plc (UK), Rossmax International Ltd (Taiwan), Briggs Healthcare (US), GF Health Products, Inc. (US), Beurer GmBH (Germany), Agilent Technologies, Inc. (US), Drive DeVilbiss Healthcare (US), Invacare Corporation (US), and B. Braun Melsungen AG (Germany).|
|Key Market Opportunities||The Outbreak of COVID-19, Leading to Increased Demand for Respiratory Devices, including nebulizers.|
|Key Market Drivers||
Nebulizer market is projected to hold a market value of USD 1,629.7 million by 2027.
Nebulizer market is anticipated to expand at a CAGR of 7.32% by the end of 2027.
The spread of COVID-19 has resulted in a surged demand for respiratory devices, including nebulizers, which is anticipated to be the most significant factor driving the global nebulizer market.
Loss of drug during the nebulization process, side effects of nebulizer solutions, and availability of substitutes of nebulizers are likely to hinder the global nebulizer market.
OMRON Healthcare (Japan), Rossmax International Ltd (Taiwan), Koninklijke Philips N.V. (Netherlands), Vectura Group plc (UK) are some of the established players of the global nebulizer market.